Ascidian Therapeutics is a startup based in the United States, 1 tracked investor.
Ascidian Therapeutics is a company headquartered in the United States. Brouky records 1 investor associated with the company.
Ascidian Therapeutics is a biotechnology company developing RNA therapeutics that edit and replace mutated human exons to restore normal protein production for genetically defined diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.